FIT Biotech

Our vision

Our mission is to be a globally recognized DNA-vaccine and gene therapy company, through our own research.

Read more

  • Our success

    We measure our success in the value of human life

FIT Biotech aims to make a difference.

R&D Publications

Company release August 31st, 2015

Company release August 31st, 2015

Half-year interim report of FIT Biotech Oy  January 1–June 30, 2015

Read interim report here

Yhtiötiedote 31.8.2015

Yhtiötiedote 31.8.2015

FIT Biotech Oy:n puolivuosikatsaus 1.1.-30.6.2015

Lue puolivuotiskatsaus tästä

Company release August 14th, 2015

Company release August 14th, 2015

FIT Biotech to publish H1/2015 Interim Report on August 31st, 2015 at 9.00 EET

Read company release here

Yhtiötiedote 14.8.2015

Yhtiötiedote 14.8.2015

FIT Biotech julkaisee puolivuotiskatsauksen 31.8.2015 klo 8.30

Lue yhtiötiedote tästä

Press release August 12th, 2015

Press release August 12th, 2015

FIT Biotech reports change in the composition of the Board of Directors

Read company release here

RESEARCH & DEVELOPMENT

FIT Biotech’s most important R&D activity since the start of its operations has been the development of an HIV vaccine.

R&D Publications